GLP-1 Trends Informing Holistic Kidney Care

Nov. 20, 2025

GLP-1s, once seen primarily through the lens of type two diabetes management, are now being recognized for their profound protective benefits for both cardiovascular and kidney health. Now, the healthcare community is leveraging evolving research to engage in a broad re-evaluation of how it manages costly chronic...

READ MORE

Press Releases
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
Nov 14, 2025

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat at the Wolfe Research Healthcare Conference on Monday, November 17,...

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
Nov 4, 2025

Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON, Nov. 4, 2025...

DaVita Inc. 3rd Quarter 2025 Results
Oct 29, 2025

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. "Our third quarter performance was in line with our expectations and keeps us on track...

Read more